Skip to main
BIOX

BIOX Stock Forecast & Price Target

BIOX Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Bioceres Crop Solutions Corp demonstrates a robust underlying Crop Protection portfolio, maintaining strong international performance even with some market share decline in Argentina, and is well-positioned for a potential recovery in local farmer demand. The company has identified significant international revenue opportunities, particularly for its HB4 wheat products across the US, Brazil, and Australia, which are expected to contribute positively despite a gradual revenue ramp-up. Additionally, the company has seen strong sales momentum in bio-protection products and adjuvants in various international markets, effectively offsetting weaker domestic performance.

Bears say

Bioceres Crop Solutions Corp has demonstrated a significant decline in revenue, primarily driven by weaker demand for its Crop Protection and Crop Nutrition segments in Argentina, compounded by reduced contributions from HB4-related sales following a strategic shift to a licensing-based business model. Specifically, Crop Nutrition revenues decreased approximately 34% year-over-year to around $25 million, largely due to declining demand and pricing pressures in the fertilizer market, influenced by reduced corn acreage. Additionally, the Seed & Integrated products segment experienced a drastic revenue drop of approximately 75% year-over-year to around $8 million as the company transitioned its HB4 program, further exacerbating concerns regarding its financial stability.

BIOX has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Bioceres Crop Solutions Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Bioceres Crop Solutions Corp (BIOX) Forecast

Analysts have given BIOX a Buy based on their latest research and market trends.

According to 3 analysts, BIOX has a Buy consensus rating as of Jan 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $4.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $4.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Bioceres Crop Solutions Corp (BIOX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.